APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase.

In the absence of the viral vif gene, human immunodeficiency virus (HIV) may be restricted by the APOBEC3G gene on chromosome 22. The role of the HIV Vif protein is to exclude host cell APOBEC3G from the budding virion. As APOBEC3G shows sequence homology to cytidine deaminases, it is presumed that in the absence of Vif, cytidine residues in the cDNA are deaminated yielding uracil. It is not known if additional proteins mediate APOBEC3G function or if deamination occurs in concert with reverse transcription. This report describes an in vitro assay showing that Baculovirus derived APOBEC3G alone extensively deaminates cDNA independently of reverse transcriptase. It reproduces the dinucleotide context typical of G --> A hypermutants derived from a Delta(vif) virus. By using an RNaseH- form of reverse transcriptase, it was shown that the cDNA has to be free of its RNA template to allow deamination. APOBEC3G deamination of dC or dCTP was not detected. In short, APOBEC3G is a single-stranded DNA cytidine deaminase capable of restricting retroviral replication.

[1]  Reuben S Harris,et al.  Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo. , 2004, Journal of molecular biology.

[2]  Reuben S Harris,et al.  The Vif Protein of HIV Triggers Degradation of the Human Antiretroviral DNA Deaminase APOBEC3G , 2003, Current Biology.

[3]  Yunkai Yu,et al.  Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex , 2003, Science.

[4]  T. Honjo,et al.  RNA-editing cytidine deaminase Apobec-1 is unable to induce somatic hypermutation in mammalian cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Malim,et al.  The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif , 2003, Nature Medicine.

[6]  M. Marin,et al.  HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation , 2003, Nature Medicine.

[7]  B. Cullen HIV-1 Vif: counteracting innate antiretroviral defenses. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[8]  S. Wain-Hobson,et al.  Death and the retrovirus. , 2003, Trends in molecular medicine.

[9]  W. Greene,et al.  HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. , 2003, Molecular cell.

[10]  John M. Coffin,et al.  Weapons of Mutational Destruction , 2003, Science.

[11]  S. Goff Death by Deamination A Novel Host Restriction System for HIV-1 , 2003, Cell.

[12]  R. König,et al.  Species-Specific Exclusion of APOBEC3G from HIV-1 Virions by Vif , 2003, Cell.

[13]  Wesley I. Sundquist,et al.  Good to CU , 2003, Nature.

[14]  M. Goodman,et al.  Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation , 2003, Nature.

[15]  Hui Zhang,et al.  The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA , 2003, Nature.

[16]  Gersende Caron,et al.  Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts , 2003, Nature.

[17]  M. Malim,et al.  DNA deamination: not just a trigger for antibody diversification but also a mechanism for defense against retroviruses , 2003, Nature Immunology.

[18]  M. Malim,et al.  DNA Deamination Mediates Innate Immunity to Retroviral Infection , 2003, Cell.

[19]  Reuben S Harris,et al.  Immunity through DNA deamination. , 2003, Trends in biochemical sciences.

[20]  F. Clavel,et al.  Hypermutation of HIV-1 DNA in the Absence of the Vif Protein , 2003, Science.

[21]  M. Malim,et al.  Comprehensive Investigation of the Molecular Defect in vif-Deficient Human Immunodeficiency Virus Type 1 Virions , 2003, Journal of Virology.

[22]  M. Nussenzweig,et al.  Transcription enhances AID-mediated cytidine deamination by exposing single-stranded DNA on the nontemplate strand , 2003, Nature Immunology.

[23]  F. Alt,et al.  Transcription-targeted DNA deamination by the AID antibody diversification enzyme , 2003, Nature.

[24]  M. Goodman,et al.  Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Reuben S Harris,et al.  RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. , 2002, Molecular cell.

[26]  M. Malim,et al.  Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein , 2002, Nature.

[27]  M. Neuberger,et al.  AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification , 2002, Nature.

[28]  Michel Henry,et al.  Sustained G-->A hypermutation during reverse transcription of an entire human immunodeficiency virus type 1 strain Vau group O genome. , 2002, The Journal of general virology.

[29]  I. Dunham,et al.  An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. , 2002, Genomics.

[30]  N. Navaratnam,et al.  Novel Role for RNA-binding Protein CUGBP2 in Mammalian RNA Editing , 2001, The Journal of Biological Chemistry.

[31]  F. McCutchan,et al.  Human Immunodeficiency Virus Type 1 DNA Sequences Genetically Damaged by Hypermutation Are Often Abundant in Patient Peripheral Blood Mononuclear Cells and May Be Generated during Near-Simultaneous Infection and Activation of CD4+ T Cells , 2001, Journal of Virology.

[32]  J. Arnold,et al.  The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen , 2000, Nature Medicine.

[33]  L. Mansky In Vivo Analysis of Human T-Cell Leukemia Virus Type 1 Reverse Transcription Accuracy , 2000, Journal of Virology.

[34]  A. Fischer,et al.  Activation-Induced Cytidine Deaminase (AID) Deficiency Causes the Autosomal Recessive Form of the Hyper-IgM Syndrome (HIGM2) , 2000, Cell.

[35]  T. Honjo,et al.  Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme , 2000, Cell.

[36]  L. Pearl,et al.  A read-ahead function in archaeal DNA polymerases detects promutagenic template-strand uracil. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Mullins,et al.  Lethal mutagenesis of HIV with mutagenic nucleoside analogs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[38]  R. Desrosiers,et al.  Identification of Highly Attenuated Mutants of Simian Immunodeficiency Virus , 1998, Journal of Virology.

[39]  S. Günther,et al.  Naturally occurring hepatitis B virus genomes bearing the hallmarks of retroviral G-->A hypermutation. , 1997, Virology.

[40]  A. Meyerhans,et al.  HIV genetic variation is directed and restricted by DNA precursor availability. , 1997, Journal of molecular biology.

[41]  L. M. Mansky,et al.  The mutation rate of human immunodeficiency virus type 1 is influenced by the vpr gene. , 1996, Virology.

[42]  Miguel Ángel Martínez,et al.  Exploring the functional robustness of an enzyme by in vitro evolution. , 1996, The EMBO journal.

[43]  S. Wain-Hobson,et al.  Human immunodeficiency virus type 1 reverse transcriptase tG:T mispair formation on RNA and DNA templates with mismatched primers: a kinetic and thermodynamic study. , 1995, The EMBO journal.

[44]  L. M. Mansky,et al.  Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase , 1995, Journal of virology.

[45]  A Gazit,et al.  Erratic G-->A hypermutation within a complete caprine arthritis-encephalitis virus (CAEV) provirus. , 1995, Virology.

[46]  P. Charneau,et al.  A highly defective HIV-1 group O provirus: evidence for the role of local sequence determinants in G-->A hypermutation during negative-strand viral DNA synthesis. , 1995, Virology.

[47]  S. Wain-Hobson,et al.  Hypermutagenesis of RNA using human immunodeficiency virus type 1 reverse transcriptase and biased dNTP concentrations. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[48]  W. Stemmer Rapid evolution of a protein in vitro by DNA shuffling , 1994, Nature.

[49]  M Sala,et al.  G-->A hypermutation of the human immunodeficiency virus type 1 genome: evidence for dCTP pool imbalance during reverse transcription. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[50]  J. Fitzgibbon,et al.  A new type of G-->A hypermutation affecting human immunodeficiency virus. , 1993, AIDS research and human retroviruses.

[51]  C. Burant,et al.  Molecular cloning of an apolipoprotein B messenger RNA editing protein. , 1993, Science.

[52]  F. Gao,et al.  Human infection by genetically diverse SIVSM-related HIV-2 in West Africa , 1992, Nature.

[53]  L. Whetter,et al.  The surface envelope protein gene region of equine infectious anemia virus is not an important determinant of tropism in vitro , 1992, Journal of virology.

[54]  R. Yolken,et al.  Use of modified nucleotides and uracil-DNA glycosylase (UNG) for the control of contamination in the PCR-based amplification of RNA. , 1992, Molecular and cellular probes.

[55]  A. Meyerhans,et al.  Selection, recombination, and G----A hypermutation of human immunodeficiency virus type 1 genomes , 1991, Journal of virology.

[56]  V. Pathak,et al.  Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: substitutions, frameshifts, and hypermutations. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[57]  Roberto Cattaneo,et al.  Biased hypermutation and other genetic changes in defective measles viruses in human brain infections , 1988, Cell.

[58]  J. Mullins,et al.  The genome organization of STLV-3 is similar to that of the AIDS virus except for a truncated transmembrane protein , 1987, Cell.

[59]  Xianghui Yu,et al.  Induction of APOBEC 3 G Ubiquitination and Degradation by an HIV-1 Vif-Cul 5-SCF Complex , 2022 .